Skip to content

Low Dose Tomosynthesis Compared to Traditional Tomosynthesis

Low Dose Tomosynthesis Compared to Traditional Tomosynthesis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02771444
Enrollment
17
Registered
2016-05-13
Start date
2016-12-31
Completion date
2018-03-22
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Brief summary

This study aims to evaluate image quality of a low-dose tomosynthesis system versus a comparator. Subjects will undergo a four-view tomosynthesis examination with the comparator and with the study device, and images will be assessed by several radiologists by comparing details in the images from the two systems.

Detailed description

Tomosynthesis is a relatively new technology to acquire mammographic images where images are acquired over several projection angles, giving 3d information that can help radiologists assess images. The aim of the study is to see whether a new low-dose tomosynthesis system has comparable image quality at a lower x-ray radiation dose to a comparator.

Interventions

DEVICETomo Assessment

A four-view tomosynthesis examination

Sponsors

Philips Digital Mammography Sweden AB
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

This is an imaging study. All participants will be imaged using two modalities. All participant data will be deidentified.

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Woman over 40 years of age * Has a tomosynthesis examination with comparator * Has a mammographic finding

Exclusion criteria

* Pregnant, breastfeeding or believes she may be pregnant * Unable or unwilling to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
X-ray dose4 monthsX-ray dose will be measured per projection.

Secondary

MeasureTime frameDescription
Lesion conspicuity comparison of images from study device vs comparator4 monthsLesion conspicuity will be assessed by image readers (radiologists) comparing the conspicuity of the same lesion imaged with the study device to the comparator

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026